Cargando…
Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926420/ https://www.ncbi.nlm.nih.gov/pubmed/36786959 http://dx.doi.org/10.1007/s40264-023-01275-7 |
| _version_ | 1784888276310556672 |
|---|---|
| author | Kälkner, Karl Mikael Sundström, Anders Nurminen, Marja-Leena Larsson, Maria Ljung, Rickard Arthurson, Veronica |
| author_facet | Kälkner, Karl Mikael Sundström, Anders Nurminen, Marja-Leena Larsson, Maria Ljung, Rickard Arthurson, Veronica |
| author_sort | Kälkner, Karl Mikael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9926420 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99264202023-02-14 Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency Kälkner, Karl Mikael Sundström, Anders Nurminen, Marja-Leena Larsson, Maria Ljung, Rickard Arthurson, Veronica Drug Saf Research Letter Springer International Publishing 2023-02-14 2023 /pmc/articles/PMC9926420/ /pubmed/36786959 http://dx.doi.org/10.1007/s40264-023-01275-7 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Research Letter Kälkner, Karl Mikael Sundström, Anders Nurminen, Marja-Leena Larsson, Maria Ljung, Rickard Arthurson, Veronica Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency |
| title | Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency |
| title_full | Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency |
| title_fullStr | Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency |
| title_full_unstemmed | Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency |
| title_short | Optimizing Safety Surveillance for COVID-19 Vaccines at the Swedish Medical Products Agency |
| title_sort | optimizing safety surveillance for covid-19 vaccines at the swedish medical products agency |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926420/ https://www.ncbi.nlm.nih.gov/pubmed/36786959 http://dx.doi.org/10.1007/s40264-023-01275-7 |
| work_keys_str_mv | AT kalknerkarlmikael optimizingsafetysurveillanceforcovid19vaccinesattheswedishmedicalproductsagency AT sundstromanders optimizingsafetysurveillanceforcovid19vaccinesattheswedishmedicalproductsagency AT nurminenmarjaleena optimizingsafetysurveillanceforcovid19vaccinesattheswedishmedicalproductsagency AT larssonmaria optimizingsafetysurveillanceforcovid19vaccinesattheswedishmedicalproductsagency AT ljungrickard optimizingsafetysurveillanceforcovid19vaccinesattheswedishmedicalproductsagency AT arthursonveronica optimizingsafetysurveillanceforcovid19vaccinesattheswedishmedicalproductsagency |